HMD Pharma Consultancy SRL
HMD Pharma Consultancy reported total assets of 85,748 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Sep 2026).
The score of HMD Pharma Consultancy shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
HMD Pharma Consultancy's annual accounts
| 2025 | |
|---|---|
| Net result | 73,006 € |
| Equity | 75,006 € |
| Cash | 48,377 € |
| EBITDA | 73,430 € |
| Total assets | 85,748 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Sep 2026
HMD Pharma Consultancy's financial analysis
- Solvency87.5%sector median: 28.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of HMD Pharma Consultancy
HMD Pharma Consultancy's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1013.637.627
- VAT number
- BE1013637627
- Peppol
- Registered · 0208:1013637627 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Sep 2024
- Registered office
- 1080 Molenbeek-Saint-Jean
- Latest accounts
- 2025 · filed on 01 Sep 2026
- Activity
- Activities of agents involved in non-specialised wholesale (NACE 46190)
HMD Pharma Consultancy (SRL) has been based in Molenbeek-Saint-Jean since 2024, active in: activities of agents involved in non-specialised wholesale. For 2025, it reports a net profit of 73,006 € and equity of 75,006 €; its revenue is not published. Its solvency stands at 87.5%, above the median of its sector (28.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to HMD Pharma Consultancy
Companies in the same business, of comparable size and area, outside its group.
- Deli Océan Business and other management consultancy activities Namur · balance sheet 170,847 €
- D-advice Activities of agents involved in non-specialised wholesale Dilbeek · balance sheet 32,970 €
- Woody Belgium Activities of agents involved in non-specialised wholesale Auderghem · balance sheet 95,216 €
- BE Health Activities of agents involved in non-specialised wholesale Etterbeek · balance sheet 122,970 €
- D En Bulle Activities of agents involved in the wholesale of other particular products Waremme · balance sheet 8,363 €
- R & Co Activities of agents involved in non-specialised wholesale Saint-Georges-sur-Meuse · balance sheet 62,290 €
- Prestige Cosmetic Activities of agents involved in non-specialised wholesale Grâce-Hollogne · balance sheet 70,523 €
- BNKL Management Activities of agents involved in non-specialised wholesale Schoten · balance sheet 44,294 €
Frequently asked questions about HMD Pharma Consultancy
What is the revenue of HMD Pharma Consultancy?
HMD Pharma Consultancy files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of HMD Pharma Consultancy?
In Belgium, the VAT number is the company number prefixed with BE: BE1013637627 for HMD Pharma Consultancy, if the company is VAT-registered. Its company number (CBE) is 1013.637.627.
Where is the registered office of HMD Pharma Consultancy?
According to the CBE register, the registered office of HMD Pharma Consultancy is in 1080 Molenbeek-Saint-Jean.
What is the equity of HMD Pharma Consultancy?
At the close of the 2025 financial year, the equity of HMD Pharma Consultancy amounts to 75,006 €, a solvency of 87.5% of total assets.
Who manages HMD Pharma Consultancy?
The register lists 1 active mandates at HMD Pharma Consultancy. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of HMD Pharma Consultancy
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →